» Roundtable Discussions: Alumkal Reviews Challenges in a Case of mCRPC - Targeted Oncology
02/08/21 15:00 from BRCA - Google News
Roundtable Discussions: Alumkal Reviews Challenges in a Case of mCRPC    Targeted Oncology

» Research Efforts Seek to Unlock the Potential of PARP Inhibition in Thoracic Malignancies - OncLive
01/08/21 11:44 from BRCA - Google News
Research Efforts Seek to Unlock the Potential of PARP Inhibition in Thoracic Malignancies    OncLive

» Bobbie Evolves the Conversation Around How We Feed Our Babies to be More Inclusive of All Parents - KULR-TV
01/08/21 07:02 from BRCA - Google News
Bobbie Evolves the Conversation Around How We Feed Our Babies to be More Inclusive of All Parents    KULR-TV

» Bobbie Evolves the Conversation Around How We Feed Our Babies to be More Inclusive of All Parents - Cadillac News
01/08/21 07:02 from BRCA - Google News
Bobbie Evolves the Conversation Around How We Feed Our Babies to be More Inclusive of All Parents    Cadillac News

» A report on the 73th Annual Congress of the Japan Society of Obstetrics and Gynecology International Workshop for Junior Fellows: Risk-reducing surgery for hereditary breast and ovarian cancer - DocWire News
01/08/21 02:00 from BRCA - Google News
A report on the 73th Annual Congress of the Japan Society of Obstetrics and Gynecology International Workshop for Junior Fellows: Risk-reducing surgery for hereditary breast and ovarian cancer    DocWire News

» Cyclacel (CYCC) falls 2.55% to Close at $4.96 on July 30 - Equities.com
30/07/21 21:39 from BRCA - Google News
Cyclacel (CYCC) falls 2.55% to Close at $4.96 on July 30    Equities.com

» Dr. Patel on the Potential With PARP/Immunotherapy Combos in NSCLC - OncLive
30/07/21 16:23 from BRCA - Google News
Dr. Patel on the Potential With PARP/Immunotherapy Combos in NSCLC    OncLive

» High prevalence of cancer is expected to positively shape the PARP-inhibitors market – The Manomet Current - The Manomet Current
30/07/21 03:49 from BRCA - Google News
High prevalence of cancer is expected to positively shape the PARP-inhibitors market – The Manomet Current    The Manomet Current

» Hem/Onc Roundup: Optimizing Treatment for Childhood Leukemia, New ASCO Guidelines, and More - DocWire News
30/07/21 03:09 from BRCA - Google News
Hem/Onc Roundup: Optimizing Treatment for Childhood Leukemia, New ASCO Guidelines, and More    DocWire News

» Cyclacel (CYCC) falls 0.20% to Close at $5.09 on July 29 - Equities.com
29/07/21 21:40 from BRCA - Google News
Cyclacel (CYCC) falls 0.20% to Close at $5.09 on July 29    Equities.com

Powered by Feed Informer